Delivery Order SPE2DB22D3016-SPE2DB25FBDR3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $42,739.50 to AmerisourceBergen Drug Corp for supply of Botox 200 unit vials, with a completion date of August 20, 2025. This competitive award, issued on July 30, 2025, carries no set-aside designation and employs firm fixed pricing terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,306.80 to AmerisourceBergen Drug Corp for the supply of Botox 100 Unit Vials. This firm fixed price, competitively awarded contract was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Botox 100 unit vials valued at $10,336.32. This firm fixed-price delivery order, with a completion date of August 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. This delivery order is a child contract issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $2,564.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award was issued on July 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's existing relationship with DLA for...
- The Defense Logistics Agency awarded a delivery order valued at $4,273.95 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a $12,821.85 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials. This firm fixed price contract, with an ultimate completion date of August 14, 2025, represents a direct procurement of the pharmaceutical product without set-aside designation. The award was issued on July 24, 2025, with performance occurring at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency awarded a $21,534 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX, with a completion date of August 12, 2025. This non-set-aside competitive award was issued on July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 Unit Vials, valued at $5,128.74 under a firm fixed price contract structure. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDR3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $30,112.50 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Botox procurement under this delivery order supports the broader federal healthcare mission, enabling the company to fulfill medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.1k | 7/31/25 |